ArticleJACC. CardioOncology2019

Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection.

Adeline Gasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.